These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes. Avenet P, Léonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ, Scatton B. Eur J Pharmacol; 1996 Jan 25; 296(2):209-13. PubMed ID: 8838458 [Abstract] [Full Text] [Related]
7. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors. Igarashi K, Williams K. J Pharmacol Exp Ther; 1995 Mar 25; 272(3):1101-9. PubMed ID: 7891322 [Abstract] [Full Text] [Related]
9. Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. Williams K. Mol Pharmacol; 1994 Jul 25; 46(1):161-8. PubMed ID: 8058050 [Abstract] [Full Text] [Related]
10. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. Coughenour LL, Barr BM. J Pharmacol Exp Ther; 2001 Jan 25; 296(1):150-9. PubMed ID: 11123375 [Abstract] [Full Text] [Related]
11. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons. Kashiwagi K, Fukuchi J, Chao J, Igarashi K, Williams K. Mol Pharmacol; 1996 Jun 25; 49(6):1131-41. PubMed ID: 8649353 [Abstract] [Full Text] [Related]
12. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. Williams K. Mol Pharmacol; 1994 Sep 25; 46(3):531-41. PubMed ID: 7935335 [Abstract] [Full Text] [Related]
13. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. Whittemore ER, Ilyin VI, Woodward RM. J Pharmacol Exp Ther; 1997 Jul 25; 282(1):326-38. PubMed ID: 9223571 [Abstract] [Full Text] [Related]